Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) has submitted a supplemental new drug application (SNDA) to the U.S. Food and ...

Intra-Cellular submitted its application to the FDA for Caplyta’s approval in major depressive disorder, potentially opening ...

The Bipolar Disorder Drugs and Treatment Market is projected to grow at a CAGR of 2.72%, reaching USD 5.8 billion by 2033.

Therapies announced that it has recently submitted a supplemental New Drug Application, sNDA, to the U.S. Food and Drug ...

About one-third of U.S. adults without diabetes who are eligible for weight loss treatment with glucagon-like peptide 1 ...

Researchers have worked with health partners in east Africa to unveil an integrated care model for treating major depressive disorder.

But doing nothing won't help.Sport and exercise are often an integral part of both inpatient and outpatient depression therapy, notes Jens Kleinert, professor of sport and health psychology at the ...

Javier Muniz, M.D. - Vice President of Research and Development Strategy, MindMed (Photo: Business Wire) ...

A study reveals that combining fitness tracker data with machine learning algorithms can effectively predict mood episodes in individuals with bipolar disorder.

Gate Neurosciences, a synaptic health biotechnology company focused on advancing next-generation precision central nervous system (CNS) treatments, today announced the initiation of a Phase 2 clinical ...

Common signs of depression include: n Feeling sad or down most of the day, nearly every day (in children, this might appear as anger or irritability) For about 5% of people in the U.S., especially in ...